Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ONO 1301

Known as: ONO-1301 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND ONO-1301, a novel sustained-release prostacyclin agonist, has an anti-fibrotic effect on the lungs, heart, and kidneys… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2013
2013
The purpose of this study was to investigate the physicochemical stability of ONO-1301 in poly(lactide-co-glycolide) microspheres… Expand
Is this relevant?
2013
2013
The purpose of this study was to evaluate the angiogenic potency of ONO-1301, a novel prostacyclin agonist, using a murine sponge… Expand
Is this relevant?
2012
2012
Tubulointerstitial injuries are crucial histological alterations that predict the deterioration of renal function in chronic… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
OBJECTIVES ONO-1301 was developed as a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity. In… Expand
Is this relevant?
2009
2009
Impairment of cardiac function in cardiomyopathy has been postulated to be related to decreased blood flow and increased collagen… Expand
Is this relevant?
2008
2008
RATIONALE Although prostacyclin is recognized as a therapeutic breakthrough for pulmonary hypertension, it needs continuous… Expand
Is this relevant?
2007
2007
It has been shown previously that administration of angiogenic growth factors as genes or proteins can augment collateral growth… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2006
Highly Cited
2006
The balance between prostacyclin and thromboxane A2 (TXA2) plays an important role in pulmonary homeostasis. However, little… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1997
1997
The antinephritic effects of ONO-1301 ([7,8-dihydro-5-[(E)-[[a-(3-pyridyl)benzylidene]-aminooxy]ethyl]-1 -naphtyloxy]acetic acid… Expand
Is this relevant?